can retatrutide affect sleep side effects: GI, heart, skin & long-term risk Sleep Issues on Retatrutide… and

Berberine has shown promise in some trials for improving glycaemic control in type 2 diabetes, with mechanisms possibly involving improved insulin sensitivity and altered gut microbiota

Upgrade vs Switch: The Practical Decision For patients currently on Wegovy 2.4 mg who have hit a weight loss plateau, the decision framework is straightforward: Upgrade to Wegovy HD 7.2 mg: Simplest path same drug, same brand, same pharmacy, same dosing schedule

It was approved in the UK in 2023 for weight management in adults with: BMI 30 kg/m (obesity), or BMI 27 kg/m (overweight) with at least one weight-related condition The medication works through several mechanisms: Reduces hunger signals by acting on the brains appetite control centre Slows stomach emptying , creating longer-lasting fullness after meals Reduces food cravings , particularly for ultra-processed foods Improves blood sugar control by enhancing insulin function Clinical trials show that people taking Wegovy lose an average of 15% of their body weight after 68 weeks, compared to 2.4% with placebo

Improved surface adhesion and wound healing effect of madecassoside liposomes modified by temperature-responsive PEG-PCL-PEG copolymers

This can help with hyperpigmentation, uneven skin tone, and improving skin elasticity